Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis

Treating ocular involvement in eosinophilic granulomatosis with polyangiitis (EGPA) can be challenging. We present the case of a 37-year-old woman with EGPA who had severe bilateral visual field defects. Laboratory results showed leukocytosis (17,500 WBC/μL, 25.8 % eosinophils), negative MPO-ANCA ti...

Full description

Bibliographic Details
Main Authors: Yuto Motobayashi, Chiyako Oshikata, Yuka Kodama, Kosuke Terada, Yuga Yamashita, Ryo Nakadegawa, Hinako Masumitsu, Reeko Osada, Hirokazu Takayasu, Nami Masumoto, Saki Manabe, Takeshi Kaneko, Akira Shiraishi, Naomi Tsurikisawa
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007124000030
_version_ 1797319433737207808
author Yuto Motobayashi
Chiyako Oshikata
Yuka Kodama
Kosuke Terada
Yuga Yamashita
Ryo Nakadegawa
Hinako Masumitsu
Reeko Osada
Hirokazu Takayasu
Nami Masumoto
Saki Manabe
Takeshi Kaneko
Akira Shiraishi
Naomi Tsurikisawa
author_facet Yuto Motobayashi
Chiyako Oshikata
Yuka Kodama
Kosuke Terada
Yuga Yamashita
Ryo Nakadegawa
Hinako Masumitsu
Reeko Osada
Hirokazu Takayasu
Nami Masumoto
Saki Manabe
Takeshi Kaneko
Akira Shiraishi
Naomi Tsurikisawa
author_sort Yuto Motobayashi
collection DOAJ
description Treating ocular involvement in eosinophilic granulomatosis with polyangiitis (EGPA) can be challenging. We present the case of a 37-year-old woman with EGPA who had severe bilateral visual field defects. Laboratory results showed leukocytosis (17,500 WBC/μL, 25.8 % eosinophils), negative MPO-ANCA titer, and elevated PR3-ANCA level (33.2 IU/mL). Diffusion-weighted MRI revealed bilateral hyperintense occipital lesions, which were more prominent on the left. Her therapy initially included a steroid pulse, followed by daily prednisolone, but her visual field defects remained refractory. The addition of intravenous cyclophosphamide (5 courses) and intravenous immunoglobulin decreased her optic neuropathy and resolved her visual field defects.
first_indexed 2024-03-08T04:07:49Z
format Article
id doaj.art-ad5fcb53e8004ffda62f3f4f52cd98cf
institution Directory Open Access Journal
issn 2213-0071
language English
last_indexed 2024-03-08T04:07:49Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj.art-ad5fcb53e8004ffda62f3f4f52cd98cf2024-02-09T04:48:14ZengElsevierRespiratory Medicine Case Reports2213-00712024-01-0147101980Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitisYuto Motobayashi0Chiyako Oshikata1Yuka Kodama2Kosuke Terada3Yuga Yamashita4Ryo Nakadegawa5Hinako Masumitsu6Reeko Osada7Hirokazu Takayasu8Nami Masumoto9Saki Manabe10Takeshi Kaneko11Akira Shiraishi12Naomi Tsurikisawa13Department of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, Japan; Department of Allergy and Respirology, Hiratsuka City Hospital, 1-19-1 Minamihara, Hiratsuka, Kanagawa, 254-0065, Japan; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, Japan; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, JapanDepartment of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, JapanDepartment of Ophthalmology, Hiratsuka City Hospital, 1-19-1 Minamihara, Hiratsuka, Kanagawa, 254-0065, JapanDepartment of Respirology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, Japan; Department of Allergy and Respirology, Hiratsuka City Hospital, 1-19-1 Minamihara, Hiratsuka, Kanagawa, 254-0065, Japan; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan; Corresponding author. Department of Respirology, National Hospital Organization Yokohama Medical Center 3-60-2 Harajuku, Totsuka-ku, Yokohama, 245-8575, Japan.Treating ocular involvement in eosinophilic granulomatosis with polyangiitis (EGPA) can be challenging. We present the case of a 37-year-old woman with EGPA who had severe bilateral visual field defects. Laboratory results showed leukocytosis (17,500 WBC/μL, 25.8 % eosinophils), negative MPO-ANCA titer, and elevated PR3-ANCA level (33.2 IU/mL). Diffusion-weighted MRI revealed bilateral hyperintense occipital lesions, which were more prominent on the left. Her therapy initially included a steroid pulse, followed by daily prednisolone, but her visual field defects remained refractory. The addition of intravenous cyclophosphamide (5 courses) and intravenous immunoglobulin decreased her optic neuropathy and resolved her visual field defects.http://www.sciencedirect.com/science/article/pii/S2213007124000030ANCA-Associated vasculitisCyclophosphamideEosinophilic granulomatosis with polyangiitisIVIGOptic neuritisVisual field defects
spellingShingle Yuto Motobayashi
Chiyako Oshikata
Yuka Kodama
Kosuke Terada
Yuga Yamashita
Ryo Nakadegawa
Hinako Masumitsu
Reeko Osada
Hirokazu Takayasu
Nami Masumoto
Saki Manabe
Takeshi Kaneko
Akira Shiraishi
Naomi Tsurikisawa
Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
Respiratory Medicine Case Reports
ANCA-Associated vasculitis
Cyclophosphamide
Eosinophilic granulomatosis with polyangiitis
IVIG
Optic neuritis
Visual field defects
title Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
title_full Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
title_fullStr Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
title_full_unstemmed Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
title_short Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
title_sort intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis
topic ANCA-Associated vasculitis
Cyclophosphamide
Eosinophilic granulomatosis with polyangiitis
IVIG
Optic neuritis
Visual field defects
url http://www.sciencedirect.com/science/article/pii/S2213007124000030
work_keys_str_mv AT yutomotobayashi intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT chiyakooshikata intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT yukakodama intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT kosuketerada intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT yugayamashita intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT ryonakadegawa intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT hinakomasumitsu intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT reekoosada intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT hirokazutakayasu intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT namimasumoto intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT sakimanabe intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT takeshikaneko intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT akirashiraishi intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis
AT naomitsurikisawa intravenouscyclophosphamideandimmunoglobulinamelioratedvisualfielddefectsinapatientwitheosinophilicgranulomatosiswithpolyangiitis